Search Results - hyun+jung+kim

5 Results Sort By:
Biomimetic microfluidic device in cell culture studies
This technology is a microfluidic cell culture device that replicates human organ functions by using multiple micro­channels and membranes to simulate different tissue environments in cell culture studies. It enables advanced research in drug testing, disease modeling, and personalized medicine. Background Cell culture technology faces significant...
Published: 10/4/2024   |   Inventor(s): Hyun Jung Kim, Dawori Jeong
Keywords(s):  
Category(s): Life sciences > Research tools > Tool/assay/screening platform
Nandrolone 17 Beta-Carbonates
Abstract: The available options for male contraceptives are limited. Androgens are administered as part of hormone-based male contraception and have also been used in the treatment of hypogonadism and hormone replacement therapy HRT. Many synthetic androgens require an oil-based delivery vehicle and have limited durations of action. This technology...
Published: 7/1/2024   |   Inventor(s): Richard Blye, Hyun Kim, Min Lee
Keywords(s): 19-nortestosterone, Androgenic Compounds, Blye, Male Contraceptive, Nandrolone, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Endocrinology, Collaboration Sought > Licensing, Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Reproductive Health
Cell-free RNA biomarkers capable of distinguishing cancer from premalignant disease
Summary Early cancer detection is critical for improving long-term patient survival and highlights a need for new sensitive and minimally-invasive early detection methods. The current technology includes novel sets of cell-free RNA biomarkers that can be used to potentially distinguish between malignant and pre-malignant forms of certain cancers using...
Published: 6/15/2022   |   Inventor(s): Thuy Ngo, Hyun Kim, Josiah Wagner, Breeshey Roskams-Hieter, Pavana Anur
Keywords(s): Diagnostics, Diagnostics - Cancer
Category(s): Diagnostics
Fecal Bacterial Markers for Non-Invasive Diagnosis of Colorectal Cancer
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 19 July 2018]We are inviting expressions of interest (EoI) for commercializing “Fecal Bacterial Markers for Non-invasive Diagnosis of Colorectal Cancer” technology. The innovation is developed by Professor YU Jun, Professor of Department of Medicine &...
Published: 6/20/2023   |   Inventor(s): Jun Yu, Jao Yiu Joseph Sung, Qiaoyi Liang
Keywords(s):  
Category(s): Diagnostics
Micro-RNA Makers for Colon Cancer
Invention Referene: 10/MED/349 This technology relates to methods of detecting the presence of specific RNA sequences in a biological sample for diagnosing or providing a prognosis for colon cancer (CRC). 　 　 AdvantagesEarly detection and removal of adenoma has been shown to reduce the incidence and mortality of CRC. Colonoscopy...
Published: 12/14/2020   |   Inventor(s): Jun Yu, Jao Yiu Joseph Sung, Chung Wah Wu
Keywords(s):  
Category(s): Diagnostics